MTOR and nonpapillary renal cell carcinoma: Although the mRNA level of mTOR in the M1 subcluster was low (Figure S10B), the mTOR signalling pathway was highly activated (Figure S10C), which may explain the high sensitivity to mTOR inhibitors by ccRCC‐7_O.